Regulation of Cervical Mucus Secretion

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 29, 2015

Primary Completion Date

August 23, 2017

Study Completion Date

August 23, 2017

Conditions
FertilityContraception
Interventions
DRUG

Leuprolide acetate

Following this spontaneous cycle, participants received a single intramuscular injection of leuprolide acetate (11.25mg, LupronVR; Abbvie, Chicago, IL), a dose documented to suppress ovarian function for at least 3 months. Ovarian suppression is confirmed with serum E2 less than or equal to 35 pg/ml 21-28 day post-injection.

DRUG

Estrogen and Progesterone Replacement

Replace hormones exogenously to create an artificial cycle

DRUG

Progestin

Synthetic progestin to assess effects on cervical mucus.

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

Oregon Health and Science University

OTHER

NCT02969590 - Regulation of Cervical Mucus Secretion | Biotech Hunter | Biotech Hunter